VPRBP Inhibitors

VPRBP inhibitors, as defined here, are a class of chemicals that indirectly influence the activity and function of VPRBP. These inhibitors do not directly target VPRBP but exert their effects through pathways in which VPRBP is involved. The primary areas of influence include DNA damage response, cell cycle regulation, and DNA repair pathways. By modulating these pathways, these chemicals can indirectly impact VPRBP's role in the cell.

The inhibitors in this class are diverse, targeting various enzymes and proteins that are upstream or interlinked with VPRBP's functional pathways. For instance, CDK4/6 inhibitors like Palbociclib may affect VPRBP's role in cell cycle regulation by altering the activity of cyclin-dependent kinases, key players in cell cycle progression. Similarly, PARP inhibitors such as Olaparib and ATR inhibitors (e.g., AZD6738 and VE-821) might modulate VPRBP's involvement in DNA repair processes. These inhibitors impact the cellular response to DNA damage, a process in which VPRBP has been implicated. Further, the role of VPRBP in p53-related pathways suggests that MDM2 inhibitors like Nutlin-3 could indirectly influence its function. Kinase inhibitors, including Chk1 inhibitors (e.g., AZD7762, MK-8776) and ATM inhibitors (like KU-55933), represent another significant group in this class. These compounds target key kinases involved in the DNA damage response and cell cycle checkpoints, thereby affecting VPRBP's associated activities.